Notable Labs Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-11.26	-14.41	-16.05
Depreciation & Amortization	0.26	0.32	0.33
Loss (Gain) From Sale of Assets	-	0.04	-
Loss (Gain) From Sale of Investments	-	0	-0.04
Stock-Based Compensation	0.59	0.58	0.78
Other Operating Activities	-2.6	1.7	-0.17
Change in Accounts Payable	0.77	0.1	0.05
Change in Other Net Operating Assets	-1.47	0.01	0.04
Operating Cash Flow	-13.72	-11.64	-15.05
Capital Expenditures	-0.07	-0.04	-0.44
Sale of Property, Plant & Equipment	-	0.1	-
Cash Acquisitions	15.61	-	-
Investment in Securities	-	0.87	16.7
Other Investing Activities	-	-	-1.5
Investing Cash Flow	15.54	0.92	14.76
Long-Term Debt Issued	-	-	1.04
Long-Term Debt Repaid	-0.06	-	-
Net Debt Issued (Repaid)	-0.06	-	1.04
Issuance of Common Stock	0.01	0.08	0.03
Financing Cash Flow	7.82	9.9	1.07
Foreign Exchange Rate Adjustments	0.6	-	-
Net Cash Flow	10.24	-0.82	0.77
Free Cash Flow	-13.78	-11.68	-15.49
Free Cash Flow Margin	-4445.48%	-146037.50%	-5436.49%
Free Cash Flow Per Share	-4.17	-17.82	-2.74
Levered Free Cash Flow	-10.06	-6.94	-
Unlevered Free Cash Flow	-10.06	-6.94	-
Change in Net Working Capital	1.68	-0.27	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.